Printer Friendly

CLEVELAND CLINIC SCIENTISTS AWARDED CANCER RESEARCH GRANTS

 CLEVELAND CLINIC SCIENTISTS AWARDED CANCER RESEARCH GRANTS
 CLEVELAND, May 27 /PRNewswire/ -- A grant totalling $144,909 from the National Institutes of Health has been awarded to James H. Finke, Ph.D., research immunologist at The Cleveland Clinic Foundation. The grant will help to fund Finke's continuing work in finding the key to T cell unresponsiveness in human tumors.
 T cells are immune cells that help to form the body's defense system against disease. Finke hopes to find out why T cells don't fight tumors by examining the cells' own biological deficiencies at the molecular level.
 Also, a grant of $15,000 from the American Cancer Society has been awarded to Cleveland Clinic Foundation researcher Pratima S. Karnik, Ph.D. The grant will be used to advance work being done at the Clinic in the battle against breast cancer.
 Both projects are part of an overall effort by the Cleveland Clinic Cancer Center's Experimental Therapeutics Program which seeks to develop new cancer treatments.
 The Cleveland Clinic Foundation is a multispecialty academic medical center providing state-of-the art care while advancing the frontiers of medicine. Since its founding in 1921, the integration of clinical and hospital care with research and education in a private, non-profit group practice has distinguished the Cleveland Clinic in American medicine. Today at the Cleveland Clinic and Cleveland Clinic Florida, nearly 600 full-time salaried physicians represent more than 100 medical specialties and subspecialties. Every year the Cleveland Clinic and Cleveland Clinic Florida provide for more than 780,000 outpatient visits and 32,000 hospital admissions from throughout the United States and more than 80 countries.
 -0- 5/27/92
 /CONTACT: Jim Armstrong, 216-444-9455, or Marion Moseley, 216-444-9456, both of The Cleveland Clinic Foundation/ CO: The Cleveland Clinic Foundation ST: Ohio IN: MTC SU:


BM -- CL005 -- 4117 05/27/92 09:32 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 27, 1992
Words:303
Previous Article:GRACE TO ACQUIRE U.K. HEALTH CARE FIRM
Next Article:BOMBAY COMPANY ANNOUNCES SALES INCREASE FOR MAY


Related Articles
CLEVELAND CLINIC AWARDED CANCER RESEARCH GRANTS
GENE THAT FIGHTS VIRAL INFECTION DISCOVERED
CLEVELAND CLINIC AWARDED $4 MILLION RESEARCH GRANT
Cleveland Clinic Selected to Receive $425,000 Grant from Howard Hughes Medical Institute.
Cleveland Clinic Dedicates Taussig Cancer Center.
Cleveland Clinic Receives $825,000 Grant from National Multiple Sclerosis Society; Prestigious Grant to Fund Research for New MS Treatment.
Cleveland Clinic, Case Comprehensive Cancer Center To Host National Cancer Institute Nanotechnology Symposium; Cancer Nanotechnology Symposium Brings...
Cleveland BioLabs Successfully Completes $5.9 Million Financing Round; CCF Start-Up to develop agent capable of mitigating negative effects of cancer...

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters